Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04489225 · ClinicalTrials.gov registry record
Personalized Therapy Study - HFRS (TriageHF) Post Approval Study
A clinical trial of Heart Failure, sponsored by Medtronic.
- Active
- Registry status
- 2,200
- Enrollment target
- 20
- Study locations
NCT04489225: Active study of Heart Failure, sponsored by Medtronic.
NCT04489225 is a study of Heart Failure that is active but no longer recruiting, run by Medtronic. The registered enrollment target is 2,200 participants, roughly in line with the 2,043-participant average among 397 other Heart Failure trials with a reported enrollment target. The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04489225, a study of Heart Failure, is active but no longer recruiting, sponsored by Medtronic.
- ACTIVE NOT RECRUITING
- Registry status
- 2,200 participants
- Enrollment target
- 20
- Study locations
Study Summary
Medtronic is sponsoring the HFRS PAS to evaluate the HFRS feature (TriageHF) when used in routine clinical practice following commercial release. The HFRS PAS is conducted within Medtronic's Product Surveillance Registry (PSR) platform.
Primary Outcome
To estimate the positive predictive value (PPV) of HFRS High Risk Status associated with worsening heart failure
Conditions Studied
Interventions
- OTHER Observational
Study Locations (20)
Florida
- Heart Rhythm Solutions - Hollywood
- Baptist Health - Jacksonville
- Cardiovascular Institute of Northwest Florida - Panama City
- Heart & Vascular Institute of Florida - Safety Harbor
- Heart Rhythm Consultants P.A. (Sarasota Memorial Research) - Sarasota
California
- Chula Vista Cardiac Center - Chula Vista
- Cardiovascular Consultants Medical Group - Van Nuys
- Cardiology Associates Medical Group - Ventura
Colorado
- Colorado Springs Cardiology - Colorado Springs
- Denver Heart - Denver
- Colorado Heart and Vascular, PC - Lakewood
Connecticut
- Hartford Hospital - Hartford
- Yale New Haven Hospital - New Have
Arizona
- Southwest EP - Chandler
Arkansas
- Saint Vincent Heart Clinic Arkansas - Little Rock
Indiana
- Deaconess Specialty Physicians - Evansville
Iowa
- Iowa Heart - Des Moines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2028-01-31 |
What the registry record for NCT04489225 still lists
NCT04489225 is an observational study that tracks outcomes without assigning an intervention. Its 2,200 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,043-participant average among 397 other Heart Failure trials with a reported enrollment target.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT04489225 names 20 study sites across 11 states, led by Florida, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT04489225 about?
NCT04489225 is a clinical study titled "Personalized Therapy Study - HFRS (TriageHF) Post Approval Study". Medtronic is sponsoring the HFRS PAS to evaluate the HFRS feature (TriageHF) when used in routine clinical practice following commercial release. The HFRS PAS is conducted within Medtronic's Product Surveillance Registry (PSR) platform.
What is the current status of trial NCT04489225?
This trial is currently active not recruiting. The enrollment target is 2,200 participants. The study started on 2020-08-01. Estimated completion is 2028-01-31.
What conditions does trial NCT04489225 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT04489225?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT04489225?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04489225 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04489225's enrollment target sits among peer trials
2,200 41st of 397 higher than 357 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI